Exploring the Bidirectional Relationship Between Depression and Obesity

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Depression and obesity exhibit a complex bidirectional relationship, where each condition elevates the risk for the other.
• Shared underlying biological mechanisms contribute to the high comorbidity rates observed between these two conditions.

Purpose of the Study:

• To elucidate the intricate bidirectional relationship between depression and obesity.
• To identify shared biological mechanisms and socio-behavioral factors implicated in their comorbidity.
• To review pharmacotherapeutic options for managing co-occurring depression and obesity.

Main Methods:

• Literature review and synthesis of existing research on depression-obesity comorbidity.
• Exploration of neurobiological pathways including neuroinflammation, the hypothalamic-pituitary-adrenal axis, and the gut-brain axis.
• Analysis of socio-behavioral factors such as hikikomori and assessment of antidepressant efficacy.

Main Results:

• The study confirms a strong bidirectional link between depression and obesity, with each condition increasing the likelihood of the other.
• Shared biological mechanisms, including neuroinflammation, HPA axis dysregulation, and gut-brain axis dysfunction, are key contributors.
• Selective serotonin reuptake inhibitors and bupropion show promise as treatments, unlike tricyclic antidepressants.

Conclusions:

• The comorbidity of depression and obesity is driven by interconnected biological and socio-behavioral factors.
• Targeting shared pathways may offer novel therapeutic strategies for managing both conditions.
• Pharmacological interventions, specifically SSRIs and bupropion, represent viable treatment options for this patient population.